cyclopentane has been researched along with Huntington Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beggiato, S; Ferrante, A; Ferraro, L; Martire, A; Pepponi, R; Popoli, P; Tebano, MT; Varani, K; Vincenzi, F | 1 |
1 other study(ies) available for cyclopentane and Huntington Disease
| Article | Year |
|---|---|
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
Topics: Action Potentials; Adenine; Adenosine A1 Receptor Antagonists; Animals; Cerebral Cortex; Corpus Striatum; Cyclic AMP; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Female; Gene Expression Regulation; Glutamic Acid; Huntingtin Protein; Huntington Disease; In Vitro Techniques; Male; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Potassium Chloride; Protein Binding; Receptor, Adenosine A1; Signal Transduction; Statistics, Nonparametric; Synaptic Transmission; Synaptosomes; Transfection; Trinucleotide Repeat Expansion; Tritium; Xanthines | 2014 |